The possible medicinal uses of cannabis are growing, yet research on how patients use medical cannabis facility services remains scarce. This article reports on the Cannabis Care Study, in which 130 medical cannabis patients at seven facilities in the San Francisco Bay Area were surveyed to gather information about demographics, personal health practices, health outcomes, service use, and satisfaction with medical cannabis facilities. The study was modeled after Andersen's Behavioral Model of Health Services Use. Results show that patients tend to be males older than 35, identify with multiple ethnicities, and report variable symptom duration and current health status. Nearly half the sample reported substituting cannabis for alcohol and illegal drugs; 74% reported substituting it for prescription drugs. Satisfaction did not differ across study sites and was significantly higher than nationally reported satisfaction with health care. Implications for the medical cannabis community and the greater system of health and social care are discussed.
Abrams, D. (1998). Medical marijuana: Tribulations and trials. Journal of Psychoactive Drugs, 30, 163-169.
2.
Andersen, R. (1968). Behavioral model of families' use of health services. Research Series No. 25. Chicago, IL: Center for Health Administration Studies, University of Chicago.
3.
Andersen, R. (1995). Revisiting the behavioral model and access to medical care: Does it matter?Journal of Health and Social Behavior, 36, 1-10.
4.
Bradley, E., Curry, L., McGraw, S., Webster, T., Kasl, S., & Andersen, R. (2004). Intended use of informal long term care: The role of race and ethnicity. Ethnicity & Health, 9(1), 37-54.
5.
Burt, C. (2005, September 16). Pot club counts police HQ among its new neighbors. Oakland Tribune, Local 1, 7.
6.
Chang, A.E., Shiling, D.J., Stillman, R.C., Goldberg, N.H., Seipp, C.A., Barofsky, I., et al. (1979). Delta-nine-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate: A prospective randomized evaluation. Annals of Internal Medicine, 91, 819-824.
7.
Charlton, B.G. (2005). Diazepam with your dinner. Sir? The lifestyle drug-substitution strategy: A radical alcohol policy. QualitativeJournal of Medicine, 98, 457-459.
8.
Clark, P., Drain, M., & Malone, M. (2003). Addressing patients' emotional and spiritual needs . Community Journal of Quality and Safety, 29(12), 659-670.
9.
Cohen, J. (1987). Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum.
10.
Coomber, R., Oliver, M., & Morris, C. (2003). Using cannabis therapeutically in the UK: A qualitative analysis. Journal of Drug Issues, 33, 325-356.
11.
Crutchfield, R., & Gove, W. (1984). Determinants of drug use: A test of the coping hypothesis. Social Science & Medicine, 18, 503-509.
12.
Evans, R., & Stoddart, D. (1990). Producing health, consuming health care. Social Science & Medicine, 31, 1347-1363.
13.
Harris, D., Jones, R.T., Shank, R., Nath, R., Fernandez, E., Goldstein, K., et al. (2000). Self-reported marijuana effects and characteristics of 100 San Francisco medical marijuana club members. Journal of Addictive Diseases, 19, 89-103.
14.
Hays, R. (1994). The Medical Outcomes Study (MOS) measures of patient adherence. Retrieved April 19, 2004, from the RAND Corporation Web site, http://www.rand.org/health/surveys/MOS.adherence.measures.pdf.
15.
Joy, J., Watson, S., & Benson, J. (Eds.). (1999). Marijuana and medicine: Assessing the science base. Washington, DC: National Academy Press.
16.
Kaplan, S., Busner, J., Chibnall, J., & Kang, G. (2001). Consumer satisfaction at a child and adolescent state psychiatric hospital. Psychiatric Services, 52, 202-206.
17.
Kutner, N. (1987). Social ties, social support, and perceived health status among chronically disabled people. Social Science & Medicine, 25(1), 29-34.
18.
LeBow, J. (1983). Research assessing consumer satisfaction with mental health treatment: A review of findings. Evaluation and Program Planning, 6(3-4), 211-236.
19.
MacCoun, R., Kier, E., & Belkin, A. (in press). Does social cohesion determine motivation in combat? An old question with an old answer. Armed Forces & Society .
20.
Marshall, G., Hays, R., Sherbourne, C., & Wells, K. (1993). The structure of patient satisfaction with outpatient medical care. Psychological Assessment, 5(4), 477-483.
21.
McCafferey, B. (1996, December 30). The administration's response to the passage of California Proposition 215 and Arizona's Proposition 200 [Statement released by Barry McCafferey, Director of the Office of National Drug Control Policy]. Washington, DC: Executive Office of the President.
22.
McHorney, C., Ware, J., Lu, J., & Sherbourne, C. (1994). The MOS 36-item short form health survey (SF-36). III: Tests of data quality, scaling assumptions and reliability across diverse patient groups. Medical Care, 32(1), 40-66.
23.
Mikuriya, T., & Mandel, J. (2001). Cannabis substitution: Harm reduction treatment for alcoholism and drug dependence. Retrieved October 13, 2005 , from http://www.mikuriya.com/cw_cansub.html.
24.
Ogborne, A., Smart, R., & Adlaf, E. (2000). Self-reported medical use of marijuana: A survey of the general population. Canadian Medical Association Journal , 162, 1685-1686.
25.
Oregon Department of Health and Human Services. ( 2005). Oregon medical marijuana program statistics. Retrieved June 20, 2005, from http://www.oregon.gov/DHS/ph/ommp/data.shtml.
26.
Powers, T., & Bendall, D. (2004). The influence of time on changes in health status and patient satisfaction. Health Care Managers Review, 29(3), 240-248.
27.
Seligman, M. (1996). Science as an ally of practice. American Psychologist, 51(10), 1072-1079.
28.
Stewart, A., Sherbourne, C., Hays, R., Wells, K., Nelson, E., Kamberg, C., et al. (1992). Summary and discussion of MOS measures . In A. L. Stewart and J. Ware (Eds.), Measuring functioning and well-being: The medical outcomes study approach (pp. 345-371). Durham, NC: Duke University Press.
29.
Swift, W., Gates, P., & Dillon, P. (2005). Survey of Australians using cannabis for medical purposes. Harm Reduction Journal, 2, 18-27.
30.
U.S. House of Representatives. (2002). Marijuana: Early experiences with four states' laws that allow use for medical purposes. Washington, DC: General Accounting Office. Retrieved February 27, 2005, from http://www.gao.gov/new.items/d03189.pdf.
31.
Ware, M., Adams, H., & Guy, G. (2005). The medicinal use of cannabis in the UK: Results of a nationwide survey. International Journal of Clinical Practice, 59, 291-295.
32.
Ware, J., & Sherbourne, C. (1992). The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473-483.
33.
Ware, J., Snyder, M., & Wright, W. (1976). Development and validation of scales to measure patient satisfaction with medical care services: Vol. 1 Part B. Results regarding scales constructed from the patient satisfaction questionnaire and measure of other health care perceptions (NTIS Publ. No. PB 288-330). Springfield, VA: National Technical Information Service .
34.
Weinrich, S.P., Weinrich, M.C., Priest, J., Fodi, C., & Talley, C.B. (2001). Perceived health status in African American and Caucasian men 40 to 70 years old. Holistic Nursing Practice , 16(1), 65-72.
